Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P890003/S483

CareLink SmartSync Device Manager Base 24970A

Medtronic, Inc. · Decision date Dec 3, 2025

FDA DECISIONP890003/S483

What did the FDA decide?

FDA records P890003/S483 as a supplement to PMA P890003, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 3, 2025.

FDA approval order statement

an update to the substrate defect mapping process
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Dec 3, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P890003/S483
Regulatory pathway
PMA supplement
Product code
NVZ
Decision code
OK30
Decision date
Dec 3, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Pulse generator, permanent, implantable.

Product code
NVZ
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P890003/S482 · Related supplement

    CareLink SmartSync Device Manager Base

  2. P890003/S481 · Related supplement

    SYNERGYST II PULSE GENERATOR MODELS 7070 & 7071

  3. P890003/S483 received

    Application receipt date recorded by FDA.

  4. P890003/S483 · FDA decision

    30-Day Notice

  5. P890003/S484 · Related supplement

    CapSure VDD-2 Lead 5038, 5038L, 5038S Service Kit-Pacemaker Repair Kit 5873C Vitatron Brilliant S+ VDD Lead IMW14Q, IMW1

  6. P890003/S486 · Related supplement

    CapSure VDD-2 Lead (5038L, 5038S), CapSure VDD-2 Lead (5038), Service Kit-Pacemaker Repair Kit (5873C)

  7. P890003/S485 · Related supplement

    CareLink SmartSync Platform Application (M01A01); CareLink SmartSync Common Application (M01A02); CareLink SmartSync Hos

  8. P890003/S487 · Related supplement

    CareLink SmartSync Device Manager Base (24970A)

Timeline entries are records held by MedtechLedger for P890003. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P890003

Explore the linked device profile

Other records with product code NVZ

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records